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Wnt Signaling Is a Major Determinant
of Neuroblastoma Cell Lineages
Marianna Szemes*, Alexander Greenhough and Karim Malik*
Cancer Epigenetics Laboratory, School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
The neural crest (NC), which has been referred to as the fourth germ layer, comprises
a multipotent cell population which will specify diverse cells and tissues, including
craniofacial cartilage and bones, melanocytes, the adrenal medulla and the peripheral
nervous system. These cell fates are known to be determined by gene regulatory
networks (GRNs) acting at various stages of NC development, such as induction,
specification, and migration. Although transcription factor hierarchies and some of
their interplay with morphogenetic signaling pathways have been characterized, the
full complexity of activities required for regulated development remains uncharted.
Deregulation of these pathways may contribute to tumorigenesis, as in the case
of neuroblastoma, a frequently lethal embryonic cancer thought to arise from the
sympathoadrenal lineage of the NC. In this “Hypothesis and Theory” article, we utilize the
next generation sequencing data from neuroblastoma cells and tumors to evaluate the
possible influences of Wnt signaling on NC GRNs and on neuroblastoma cell lineages.
We propose that Wnt signaling is a major determinant of regulatory networks that
underlie mesenchymal/neural crest cell (NCC)-like cell identities through PRRX1 and
YAP/TAZ transcription factors. Furthermore, Wnt may also co-operate with Hedgehog
signaling in driving proneural differentiation programmes along the adrenergic (ADRN)
lineage. Elucidation of Signaling Regulatory Networks can augment and complement
GRNs in characterizing cell identities, which may in turn contribute to the design of
improved therapeutics tailored to primary and relapsing neuroblastoma.
Keywords: Wnt signaling, neuroblastoma, neural crest, gene regulatory networks, Hippo YAP/TAZ, Hedgehog
signaling
INTRODUCTION
Neuroblastoma (NB) is a frequently lethal pediatric tumor, with 75% of NBs occurring in
children under 5 years of age. About half of the tumors arise in the adrenal medulla, with
the remainder originating in the paraspinal sympathetic ganglia in the abdomen or chest, or
in pelvic ganglia. This distribution reflects the probable developmental origin of NB in the
sympathoadrenal (SA) lineage of the neural crest (NC). Clinically, NB encompasses low-risk disease
which responds well to treatment and may even spontaneously regress, and high-risk disease,
representing about 40% of total cases, which frequently relapse and have less than 50% survival.
Abbreviations: ADRN, adrenergic; EMT, epithelial-mesenchymal transition; ERK, extracellular signal–regulated kinase;
GRN, gene regulatory network; KEGG, Kyoto encyclopedia of genes and genomes; LEF, lymphoid enhancer binding
factor; MEK, MAPK/ERK kinase; MES, mesenchymal; MNA, MYCN-amplified; NB, neuroblastoma; NC, neural crest;
NCC, neural crest cell; Rspo, R-spondin; SA, sympathoadrenal; TCF, T-cell-factor.
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This clinical heterogeneity is thought to reflect both the complex
molecular etiology as well as the cellular heterogeneity of
tumors (Brodeur, 2003; Maris et al., 2007). Whilst it has
long been known that the proto-oncogene MYCN is crucial
for NC cell fate (Wakamatsu et al., 1997) and influencing
differentiation states in NB (Westermark et al., 2011), a deeper
understanding of developmental factors remains necessary to
determine the origins of NB in order to inform improved
prognosis and therapies.
In this theoretical analysis, we will consider the potential
regulatory influences and interactions of the canonical Wnt
signaling pathway in determining phenotypes in the NC and
neuroblastoma. Although this signaling pathway is known
to be critical in regulating stemness, cell fate, differentiation
and proliferation (Nusse and Clevers, 2017), much remains
unclear about its role in neuroblastoma. Based on our recent
identification of genes regulated by the Wnt ligand Wnt3a and
Wnt agonist R-spondin 2 in an NB cell-line (Szemes et al.,
2018), we assess transcriptional and signaling pathways, which
require further investigation in the contexts of NC development
and neuroblastoma.
WNT SIGNALING PATHWAYS AND
COMPONENTS
In broad terms, Wnt signaling includes ‘‘canonical’’ and ‘‘non-
canonical’’ pathways. The former is also referred to as Wnt/β-
catenin signaling, as it is dependent on cytoplasmic-nuclear
translocation of β-catenin, and its subsequent transcriptional
cofactor activity with T-cell factor/lymphoid enhancer factor
(TCF/LEF) transcription factors (Clevers and Nusse, 2012;
Nusse and Clevers, 2017). Non-canonical, or alternative Wnt
signaling pathways include the Planar cell polarity (PCP), the
Wnt/Ca2+ pathways, β-catenin-independent pathways acting
via Rho-associated kinase (ROCK) and G-protein dependent
calcium release (Komiya and Habas, 2008). More recently,
another alternative Wnt pathway has been demonstrated, where
the downstream effectors are the Hippo signaling pathway
transcriptional co-factors, Yes-associated protein (YAP) and
Transcriptional C-activator with PDZ-Binding motif (TAZ,
encoded byWWTR1, Park et al., 2015; Figure 1).
There is a complex and extensive interplay between these
pathways, reflected in the 19 Wnt ligands and 10 Frizzled (FZD)
FIGURE 1 | Overview of canonical and alternative Wnt signaling pathways. Canonical Wnt signaling is defined by the activation of β-catenin-dependent transcription
[via T-cell factor/lymphoid enhancer factor (TCF/LEF)] downstream of Wnt receptors. In the absence of Wnt ligands, β-catenin is held in the destruction complex of
proteins that includes Axin, APC, Ser/Thr kinases CK1 and GSK3, and E3-ubiquitin ligase β-TrCP. Sequential phosphorylation (by CK1 and GSK3) and ubiquitination
(by β-TrCP) of β-catenin promotes its proteosomal degradation. Binding of Wnt ligands (classically Wnt3a) to frizzled (FZD) and LRP5/6 receptors leads to recruitment
of the destruction complex to the membrane via Dvl and Axin, which blocks β-catenin ubiquitination by β-TrCP. The destruction complex then becomes saturated
with β-catenin, allowing newly synthesized β-catenin to accumulate in the cytoplasm and translocate to the nucleus where it associates with TCF/LEF transcription
factors to regulate gene expression. Rspo (R-spondin) proteins can enhance Wnt signaling by binding LGR4/5/6 receptors to antagonize the
RNF43/ZNRF3 transmembrane E3 ligases that remove Wnt receptors from the cell surface. The alternative Wnt-YAP/TAZ pathway (as defined by Park et al., 2015).
Wnt5a/b and Wnt3a ligands induce the activation of YAP/TAZ via FZD and ROR1/2 co-receptors, independently of LRP5/6 and β-catenin. Activation of
FZD-ROR1/2 couples to Gα12/13 G-protein subunits, leading to activation of RhoA and subsequent inhibition of LATS1/2 kinases (major YAP/TAZ Ser/Thr kinases).
Inhibition of LATS1/2 leads to YAP/TAZ dephosphorylation, stabilization and translocation to the nucleus where their interaction with TEAD transcription factors
promotes gene regulation. Wnt-YAP/TAZ target genes such as DKK1 lead to the inhibition of canonical Wnt/β-catenin signaling. Wnt/Ca2+ signaling. Activation of
FZD stimulates the activity of phospholipase C (PLC) via Dvl and G proteins, leading to increases in intracellular Ca2+ levels. Ca2+ activates calmodulin-dependent
protein kinase II (CaMKII), protein kinase C (PKC) and the transcription factors NFAT and ATF2. Activation of PKC by Ca2+ can cause actin cytoskeleton
rearrangements via Cdc42 activity. Wnt/PCP (planar cell polarity) signaling. Wnt signaling via FZD with co-receptors ROR1/2 or RYK may activate G proteins and Dvl
to stimulate RhoA (via Dvl-Daam) and ROCK activity, leading to rearrangement of the actin cytoskeleton. Activation of G proteins can also stimulate Rac1, leading to
JNK-mediated phosphorylation of c-JUN and transcriptional activity via AP-1.
Frontiers in Molecular Neuroscience | www.frontiersin.org 2 April 2019 | Volume 12 | Article 90
Szemes et al. Wnt Regulates Neuroblastoma Lineages
receptors. Wnt ligands are secreted, lipid-modified glycoproteins
conserved in all metazoan animals, able to act as morphogens
over short distances (MacDonald et al., 2009). Although some
preferential usage of certain Wnt ligands by different pathways
is observed, such as Wnt3a for canonical, and Wnt5a for
non-canonical signaling, strict restriction of ligand usage by
pathways, or a ‘‘Wnt code,’’ have not emerged. Rather, numerous
other effectors and regulatory molecules add to the complexity
of the pathways (van Amerongen, 2012). In general, however,
non-canonical Wnt signaling is thought to antagonize the
canonical Wnt/β-catenin pathway (Veeman et al., 2003).
In the canonical Wnt/β-catenin pathway, Wnt ligands
are bound with high affinity by Frizzled proteins, leading
to the formation of heterodimeric membrane core receptor
complexes containing LRP5/6. Binding of Wnt ligands leads to
LRP phosphorylation and recruitment of the scaffold protein
Axin to LRP. Axin is a key component of the ‘‘destruction
complex,’’ which also includes APC, the Ser/Thr kinases
GSK-3 and CK1, protein phosphatase 2A (PP2A), and the
E3-ubiquitin ligase β-TrCP. This complex regulates cytoplasmic
β-catenin turnover through phosphorylation and proteosomal
turnover. The LRP-Axin interaction leads to inactivation of
the destruction complex, permitting β-catenin stabilization and
nuclear availability. The TCF/LEF family of transcription factors
are then able to utilize β-catenin as a transcriptional co-activator
and instigate target gene expression (Clevers and Nusse, 2012).
Further amplification of signaling can be achieved through
the participation of another set of receptors, the leucine-rich
repeat-containing G-protein coupled receptors (LGR4/5/6) and
their ligands, the R-spondins (Rspos; de Lau et al., 2011).
LGR-Rspo complexes at the cell membrane decrease the
endocytic turnover of Frizzled-LRP5/6 by neutralizing the
ubiquitin ligases RNF43 and ZNRF3 (Hao et al., 2012).
DIFFERENTIATION OF THE NEURAL
CREST AND WNT SIGNALING
The tissue of origin for neuroblastoma is the NC, a band
of cells that forms transiently between the neural tube and
the non-neural ectoderm during early vertebrate development.
Many signaling pathways act together during gastrulation
to promote NC induction and specification, especially bone
morphogenetic protein (BMP; Steventon et al., 2009), fibroblast
growth factor (FGF; Stuhlmiller and García-Castro, 2012) and
Wnt/β-catenin signaling (García-Castro et al., 2002; Leung
et al., 2016). Together, these signaling pathways orchestrate
numerous transcription factors, including MSX1/2 (Tribulo
et al., 2003; Ramos and Robert, 2005) and ETS1 (Barembaum
and Bronner, 2013). NC specification finishes with an elevation
of the neural folds during neurulation, and thereafter, following
neural tube closure, premigratory NC cells delaminate and
undergo epithelial-mesenchymal transition (EMT; Nieto et al.,
2016). Multipotent neural crest cells (NCCs) with differential
abilities to form derivative cell types are arranged along the
length of the vertebrate embryo; these can be subdivided into
the cranial, vagal, trunk and sacral NC, and will give rise to
diverse cell and tissue types, including facial cartilage and bone,
dental mesenchymal cells (Sharpe, 2016), melanocytes, smooth
muscle cells, Schwann cells and enteric neurons (Bronner and
LeDouarin, 2012; Martik and Bronner, 2017). The trunk NCCs
give rise to the sympathetic nervous system and the adrenal
medulla and are therefore the source of presumptive progenitors
of neuroblastoma cells. Interestingly, a recent report by Espinosa-
Medina et al. (2016) demonstrated that sacral NC can also give
rise to sympathetic neurons.
As well as being crucial for NC induction, canonical Wnt
signaling has also been shown to be vital in other NC
stages including a role in delamination in co-operation with
BMP; here disruption of β-catenin and TCF/LEF inhibits cell
cycle progression and NC delamination and transcription of
BMP-regulated genes, including MSX1 (Burstyn-Cohen et al.,
2004). Furthermore, ablating β-catenin specifically in NC stem
cells in vivo revealed that, despite some NC-derived structures
developing normally, mutant animals lack melanocytes and
dorsal root ganglia. β-catenin mutant NCCs appear to emigrate
normally but fail to undertake sensory neurogenesis, thereby
suggesting a role of β-catenin in premigratory/early migratory
NCCs (Hari et al., 2002). Non-canonical Wnt signaling is also
involved in NCCmigration (Mayor and Theveneau, 2014). Thus,
Wnt signaling pathways are involved at multiple stages of NC
development and can also selectively regulate NC lineages.
The aforementioned signaling pathways orchestrate cell
behavior via gene regulatory networks (GRNs) that govern NC
development. Transcriptional analysis and molecular loss and
gain-of-function studies facilitate a GRN model of the NC,
which, encompassing transcriptional regulators and signaling
molecules, can explain the formation and maintenance of NC
lineages (Martik and Bronner, 2017). Establishment of the
neural plate border, specification, migration and differentiation,
have their specific GRNs, and these networks can interact,
overlap and influence each other. Gradients and balances
of Wnt, BMP, FGF and Notch signaling determine NC
induction and activate transcription factors (e.g.,MSX1, MYCN,
DLX5/6), in the neural plate border module, determining the
boundaries of NC, neural and non-neural ectoderm. These, in
turn, upregulate NC specifier genes, which initiate the EMT
programme (including SNAI1/2, ETS1, TWIST1/2) to prepare for
delamination of NCCs as well as maintain an undifferentiated
state (premigratory module). Following EMT, the NCCs acquire
amigratory programme enabling long-distancemigration guided
by environmental signals and maintained by a TF network
(including ZEB2, LMO4, SNAI1/2, TWIST1/2, ETS1). The
sympathoadrenergic lineage follows a ventral migratory pattern
and aggregate at the dorsal aorta and go on to form the
primary sympathetic ganglia and colonize the adrenal medulla.
BMPs released by the wall of the dorsal aorta induce SA
speciation, activating ASCL1 and PHOX2B, which switches on
other SA-lineage specific transcription factors, for example,
ASCL1 upregulates PHOX2A, which in turn upregulates TH and
DBH, enzymes characteristic of the SA lineage.
MYCN, the key developmental transcription factor
deregulated in neuroblastoma, has been shown to be a Wnt
target gene in chicken limb mesenchyme (ten Berge et al., 2008).
MYCN is expressed at high levels in chick NC progenitors in
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early NC development but surprisingly is not apparent in highly
proliferative migrating NCCs (Khudyakov and Bronner-Fraser,
2009). This finding was confirmed and extended to show the
absence of MYCN expression in the condensed dorsal root and
sympathetic ganglia. Elevating MYCN expression in the neural
plate border was shown to lead to a change in NC identity,
toward a more central nervous system fate (Kerosuo et al., 2018).
Transient over-expression of ectopic MYCN in early migrating
cells, however, suggested that MYCN can regulate NC fate
by regulating ventral migration and neuronal differentiation
(Wakamatsu et al., 1997). Evidence from the developing
NC in lamprey suggests that ZIC, MSX and TFAP2A/AP-
2 transcription factors may positively regulate MYCN in the
NC (Nikitina et al., 2008), but signaling pathways upstream of
MYCN in the NC are unclear.
NEUROBLASTOMA AND WNT SIGNALING
Neuroblastomas display relatively few gene mutations, thus
limiting the options for targeted therapeutics, and relapsing
disease is common for high-risk NB (Matthay et al., 2016).
Another increasingly important consideration is the cellular
heterogeneity of NBs. Although this was first observed decades
ago in NB cell lines being able to transdifferentiate (Ciccarone
et al., 1989), the dependence of lineage identity on transcriptional
circuitries are only recently becoming evident. One study
recently established that primary NBs and NB cell lines can
contain two major cellular components, including migrating,
NCC-like mesenchymal (MES), and more committed adrenergic
(ADRN) cells. These two cell types were defined by super-
enhancer-associated gene expression patterns, characteristic of
NC lineage differentiation stages and could transdifferentiate
in vitro and in vivo. The ADRN lineage was defined by
transcription factors such as GATA2/3, PHOX2A/2B and
DLK1, whereas the MES lineage included the classical EMT
transcription factor SNAI2, together with YAP1, TAZ (encoded
by WWTR1) and PRRX1. The ADRN cells were more
tumorigenic in nude mice than MES cells, although MES
cells were more chemoresistant and were enriched in relapsed
tumors (van Groningen et al., 2017). Concomitantly, another
group also established transcriptional circuitries underlying the
heterogenous differentiation states of NB cells and termed their
three subtypes as sympathetic noradrenergic, NCC-like and a
mixed type (Boeva et al., 2017). The noradrenergic identity
required a transcription factor module containing PHOX2B,
HAND2, and GATA3 and therefore corresponds to the ADRN
subtype defined by van Groningen et al. (2017), whereas the
NCC-like overlaps with theMES subtype, given they both require
PRRX1. Importantly, ectopic overexpression of PRRX1 was
shown to be able to alter lineage identity from ADRN to MES
cells (van Groningen et al., 2017).
The prototypic route for disrupted differentiation of
NCCs leading to neuroblastoma depends on MYCN
amplification (Brodeur et al., 1984), which in turn leads
to overexpressed MYCN protein directly repressing genes
required for sympathetic nervous system terminal differentiation
(Westermark et al., 2011; Gherardi et al., 2013). Given the
many examples of cancers dependent on oncogenic Wnt/β-
catenin signaling (Clevers and Nusse, 2012), such as colorectal
cancers which have activating mutations in β-catenin or loss
of function APC mutations (Fodde and Tomlinson, 2010),
and that MYCN is a target of Wnt signaling (ten Berge et al.,
2008), it was reasonable to propose that Wnt/β-catenin signaling
would represent an oncogenic pathway in NB. This was further
supported by our demonstration that high levels of LGR5 were
apparent in undifferentiated NBs and NB cell lines (Vieira et al.,
2015) and LGR5 expression correlated with poor prognosis.
However, although we showed that LGR5 was able to function
as a Rspo2 receptor and amplify Wnt3a-induced β-catenin/TCF
transcriptional activity, marked increases in proliferation were
not observed, and the pro-survival functions of LGR5 were
shown to be attributable to LGR5 positively modulating
MEK/ERK signaling rather thanWnt/β-catenin signaling (Vieira
et al., 2015). This dual regulatory capacity of LGRs onMEK/ERK
signaling and Wnt was subsequently also demonstrated in skin
carcinogenesis (Xu et al., 2016), but the underlying mechanisms
remain unclear.
Although we found that Wnt3a/Rspo2 treatment of NB lines
lead to the induction of some established canonical Wnt target
genes, such as LEF1 and AXIN2, MYCN transcripts were not
induced. In fact, we found that MYCN and MYC protein
levels were actually reduced after Wnt3a/Rspo2 treatment, in
contrast to previous reports suggesting induction of MYC in
non-MYCN amplified (non-MNA) NBs as a result of Wnt/β-
catenin signaling (Liu et al., 2008). Furthermore, our study
did not align simply with reports showing that individual
Wnt pathway components were associated with chemoresistance
(FZD1; Flahaut et al., 2009), tumorigenic stem-like cells in
human and mouse neuroblastoma (FZD6; Cantilena et al., 2011),
and increased NB proliferation dependent on FZD2 (Zins et al.,
2016). Using Wnt chemical agonists and inhibitors another
study suggested that Wnt signaling hyperactivation promotes
apoptosis of NB cells and that Wnt inhibition decreased
proliferation and increased NB differentiation (Duffy et al.,
2016). Oncogenicity ofWnt/β-catenin signaling, via deregulation
of MYCN, was also inferred in a report demonstrating the
therapeutic benefit of glypican-2 immunotherapy for NB (Li
et al., 2017).
Given the lack of consensus on the role of Wnt signaling
in NB, we, therefore, sought to detail the phenotypic and
transcriptomic effects of Wnt signaling on NB cells by treating
three cell lines with Wnt3a and Rspo2. We determined early
(6 h) Wnt-induced transcriptomic changes by RNA sequencing
in SK-N-BE(2)-C, an MYCN-amplified (MNA) NB cell line
(Szemes et al., 2018). Using a statistical cut-off of p = <0.005,
we identified 90 genes that showed substantial and significant
changes. In parallel, longer treatments were assessed for changes
in phenotype and established that Wnt3a/Rspo2 treatment
could induce proliferation in the SK-N-AS cell line, but in
other lines, especially SK-N-BE(2)-C and SH-SY5Y cell lines,
increased proliferation was not observed. Instead, we found an
EMT-like transition, evidenced by increased cell migration and
induction of SNAI1/2 and TWIST1/2, and neural differentiation
accompanied by increased expression of marker genes such as
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NGFR, NTRK1, NEFM and NEFL/NF68. Meta-analysis of the
expression of our 90 Wnt target genes in primary tumor gene
expression databases revealed: (i) four gene subsets within the
90 genes, and (ii) dramatically different prognostic outcomes
associated with each of the four gene subsets (Figure 2). By
converting the expression of each of the four gene subsets into a
numerical model, or metagene, we were further able to show that,
for example, expression of Wnt metagene 1 (WMG-1) strongly
positively correlated with Hippo-YAP/TAZ signaling signatures
(R = >0.76) in NB, and that these genes were more highly
expressed in intermediate risk NB, rather than low- or high-risk
NB. WMG-3 was overexpressed in the high-risk NB cluster,
FIGURE 2 | Summary of Wnt target genes previously identified in
SK-N-BE(2)-C cell line (Szemes et al., 2018). K-means clustering of these
target genes in the SEQC neuroblastoma (NB) dataset (GSE62564) enabled
identification of four co-expressed Wnt target gene subsets. The combined
expression of each gene subset was converted into a single value,
represented as a metagene. The Wnt metagene groups (WMG-1, 2, 3, 4)
displayed differential expression in four prognostic clusters in the primary NB
tumor data set. Expression levels of the WMGs in the NB clusters are
indicated by the heatmap, and survival for each NB patient cluster is shown in
the last column. Bioinformatic analyses were performed by using tools
implemented in R2 (http://r2.amc.nl, http://r2platform.com).
dominated by MNA tumors. Conversely, WMG-2 showed a
strong positive correlation to Hedgehog signaling (R = >0.84)
associated with differentiation (Souzaki et al., 2010) and a
negative correlation with MYC signatures (R = −0.76). WMG-2
genes were, concordantly, strongly repressed in high-risk MNA
NB (Szemes et al., 2018).
Collectively, studies from our laboratory and from others
allude to an underappreciated role for Wnt signaling in NC and
NB biology. In particular, the induction of EMT-like changes
and the correlation of a subset of our Wnt target genes (WMG-
1) with Hippo-YAP/TAZ pathway gene signatures, seemingly
characteristic of the MES lineage (van Groningen et al., 2017),
suggest that Wnt signaling may be part of the regulatory network
determining NB cell identity. In the following sections, we will
evaluate this concept through analysis of Wnt signaling on
transcriptional and signaling pathways involved in NC and NB.
IS WNT SIGNALING A MAJOR
DETERMINANT OF NC AND NB CELL
FATE?
Numerous studies have examined the spatiotemporal expression
of transcription factors and signaling pathway components in the
NC. Integration of these efforts has facilitated the establishment
of a GRN model, underlying NC development (Martik and
Bronner, 2017). As our RNA sequencing of the NB cell line SK-
N-BE(2)-C treated withWnt3a/Rspo2 provides a unique gene set
representing, at least in part, Wnt targets in the NC, we assessed
which GRN genes encoding transcription factors or signaling
molecules from different stages of NC development might be
affected by Wnt3a/Rspo2 treatment (Table 1). As expected
from our previous work, premigratory and migratory modules,
including several EMT transcription factors (TWIST1, ZEB2,
ETS1), are affected. Interestingly, given that the presumptive
TABLE 1 | Wnt3a/RSPO-2 induction in SK-N-BE(2)-C neuroblastoma cells (ERP023744; Szemes et al., 2018) can modulate gene regulatory network (GRN) modules of
the developing neural crest (as identified in Martik and Bronner, 2017).
Neural crest GRNs Genes Wnt-induced fold change Neural crest GRNs Genes Wnt-induced fold change
Induction of the neural plate border MSX1 14.66 Pre-migratory NC ETS1 2.56
BMP4 14.22 SOX6 2.25
WNT11 4.15 TWIST1 1.81
DLX5 3.54 MYB 1.36
WNT5B 3.14 MYC 1.32
WNT4 3.06 Migratory NC WNT11 4.15
WNT2B 2.84 WNT5B 3.14
TCF7 1.85 WNT4 3.06
FGF12 1.54 WNT2B 2.84
SMAD6 1.40 ETS1 2.56
FGF18 1.36 SOX6 2.25
FGF7 0.71 TCF7 1.85
FGF19 0.53 TWIST1 1.81
Neural plate border MSX1 14.66 ZEB2 1.38
DLX5 3.54 LMO4 1.35
DLX6 1.40 WNT10A 0.70
WNT6 0.60
Sympathetic neurons BMP4 14.22
ASCL1 0.58
Enteric neurons ASCL1 0.58
Regulatory genes with a minimum change of ±1.5-fold are shown and are grouped according to the GRN modules, highlighted in different colors.
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cell of origin for NBs is along the sympathoadrenal lineage,
there is also strong induction for neural plate border specifiers
MSX1, DLX5 and DLX6. This suggests that either SK-N-BE(2)-
C cells have retained early transcriptional plasticity, or more
intriguingly, that NBs may arise prior to sympathoadrenal
differentiation. This notion is supported by developmental
experiments showing ectopic MYCN expression in the neural
plate border resulting in a shift towards a CNS-like state (Kerosuo
et al., 2018) and the induction of NB in MYCN-overexpressing
NCCs (Olsen et al., 2017).
We next assessed the relationships between the Wnt pathway
andNCCs andARDN andMES identities using publicly available
gene expression datasets. As shown in Figure 3A, transcription
factors in the Wnt pathway are significantly higher in NCCs and
MES cell lines compared with ADRN cell lines.
In order to explore if Wnt may regulate NB lineage identity,
we studied the relationship between individual Wnt pathway
members and MES and ADRN lineage identity signatures in
a primary NB dataset (SEQC498; Su et al., 2014). MES and
ADRN metagenes were constructed on the basis of the study
of van Groningen et al. (2017). We then plotted the correlation
of expression (correlation co-efficient, R) of each Wnt pathway
member gene in relation to the expression of MES and ADRN
signatures. In addition to the components of the Wnt pathway
described in Kyoto encyclopedia of genes and genomes (KEGG),
we also included LGR receptors and their ligands, R-spondins.
Wnt components showed a strong correlation to the expression
of MES signature along a gradient, with R values ranging
from 0.81 to −0.381 (Figure 3B, top panel). The association
to the ADRN signature was also pronounced (R: −0.54 to
0.48), but interestingly displaying an inverse pattern to that
of MES. The functional significance of this pattern could be
underpinned, for example, by FZD3, which has been shown to
be required for maintenance of dividing sympathetic neuroblasts
and correlates with ADRN identity (Armstrong et al., 2011). In
contrast, FZD1 and FZD6, previously reported to be associated
with chemoresistance and tumorigenic stem-cells, respectively
(Flahaut et al., 2009; Cantilena et al., 2011) correlate highly
with MES identity (Figure 3B). Although the selectivity of
Wnt-Frizzled interactions is poorly understood (Grainger and
Willert, 2018), our analysis highlights the possibility that Wnt
responses and opposing functional outcomes in NC and NB may
be regulated by Wnt receptor configurations.
We previously demonstrated that Wnt can drive the
expression of diverse sets of genes in NB cells that display distinct
co-expression patterns in primary tumors, which we represented
with Wnt metagenes. We reasoned that differential regulation of
Wnt metagenes in NB tumors could be due to the configuration
of the Wnt pathway, i.e., the differential expression of genes
encoding for the pathway components. We, therefore, assessed
the correlation of expression between Wnt pathway members
and our Wnt metagenes, WMG-1, 2, 3 and 4 (Figure 3B),
which revealed a striking similarity of WMG-1 (yellow) with
MES identity, and an anticorrelation with ADRN identity. This
was also partially true for WMG-2 (green), but to a much
lesser extent, whereas WMG-3 (red), which we had previously
associated with high-risk and MYC signatures, was generally
FIGURE 3 | Wnt pathway associations with MES phenotype in neural crest
(NC) cells and NB. (A) Expression of Wnt-related transcription factors [Kyoto
encyclopedia of genes and genomes (KEGG)] in adrenergic (ADRN),
mesenchymal (MES), and neural crest cell lines (NCC; GSE14340 and
GSE28019, van Groningen et al., 2017). Statistically significant difference
between the groups was tested by using analysis of variance (ANOVA; p
values shown) and Tukey HSD post hoc tests were applied to evaluate
pairwise differences (∗∗∗ p < 0.005). (B) Correlation of the expression of Wnt
pathway members (KEGG, LGRs and RSPOs; n = 147) with various gene
sets and prognosis in the SEQC data set (GSE62564), sorted according to
the coefficient of correlation to MES signature. The x-axis represents Wnt
pathway genes, while the y-axis indicates the correlation coefficient (R)
between the expression of the Wnt pathway gene and the indicated gene set.
The upper panel shows the inverse association of MES (orange) and ADRN
(blue) signatures to Wnt genes, while the lower panels show the correlations
of the individual Wnt metagenes to the same pathway genes. Note the very
similar pattern of correlation of WMG-1 (yellow) and MES signature to Wnt
pathway genes and the inverse profile of WMG-2 (green) and WMG-3 (red)
correlations. WMG-4 correlations are shown in gray. The bottom panel shows
the correlation of the same genes with prognosis, with the y-axis representing
Bonferroni corrected p-values of Kaplan scan analyses using event-free
survival. Green bars indicate the correlation of high expression to good
prognosis, while the red ones to poor prognosis. (C) WMG-1 expression in
adrenergic, mesenchymal and neural crest cells. (D) Correlation between
MES signature and WMG-1 in SEQC (GSE62564). Each point represents a
tumor. (E) High expression of MES signature genes is correlated to good
prognosis in the same data set.
low in MES and high in ADRN. WMG-2 and 3 had inverse
correlation profiles, consistent with their contrasting expression
patterns in NB tumors. WMG-4 (gray) correlation patterns were
not distinct.
Wnt pathway members also correlated with prognosis
(Figure 3B bottom). High expression of genes with moderate
correlation to MES or ADRN signature and high correlation
to WMG-2 were the strongest indicators of good prognosis.
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Conversely, Wnt pathway genes correlating with ADRN
signature were usually indicators of poor prognosis.
Focussing on WMG-1, we observed it was also significantly
higher in NCC and MES cells lines compared to ADRN
cells (Figure 3C), and in the SEQC dataset WMG-1 and the
MES signature showed a remarkable correlation (R = 0.927,
p = 9.0× 10−214; Figure 3D). This was also apparent in a second
NB dataset containing 649 tumors (Supplementary Figure S1A).
We had previously shown that WMG-1 expression in NB gene
expression datasets correlated with intermediate risk NB, and in
accordance with that, we found that the high expression of the
MES signature metagene correlated with a better prognosis in the
SEQC (Figure 3E) and also in the Kocak dataset of 649 tumors
(Kocak et al., 2013; Supplementary Figure S1B). As both our
FIGURE 4 | Associations between neuroblastoma Wnt target genes, PRRX1, and Hippo-YAP/TAZ signaling. (A) PRRX1 expression is significantly higher in the
intermediate risk NB Wnt cluster, which strongly associates with high WMG-1 expression (see Figure 1; GSE62564). Statistically significant difference between the
groups was tested by using ANOVA (p values shown) and Tukey HSD post hoc tests were applied to evaluate pairwise differences (∗∗∗ p < 0.005). (B) Heatmaps
showing the regulation of individual genes within the Wnt metagenes by PRRX1 (GSE908040, derived from inducible PRRX1 expression in SK-N-BE(2)-C cells). Note
the induction of WMGs 1, 2, and 4 at later timepoints, and downregulation of most WMG-3 genes. (C) Wnt3a/Rspo-2 treatment of NB cell lines for 96 h leads to the
activation of MES-related transcription factors, PRRX1, and WWTR1. (D) Volcano plot showing gene expression changes in SK-N-BE(2)-C cells with induced
PRRX1 expression. Red dots indicate members of the Hippo signaling pathway (KEGG). The highlighted Hippo pathway transcription factors and the Hippo target
gene CTGF were all strongly upregulated. Dashed lines separate genes regulated by minimum ±2-fold with p < 0.01 significance. Cell culturing and gene expression
analysis were performed as previously (Szemes et al., 2018). PCR primers are provided in Supplementary Table S1.
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WMG-1 (Szemes et al., 2018) and MES (van Groningen et al.,
2017) signatures are associated with Hippo-YAP/TAZ, it may
be inferred that Hippo signaling, which has been implicated in
NB tumorigenesis (Wang et al., 2015; Yang et al., 2017), may,
at least at diagnosis, not be integral to high-risk neuroblastoma.
Interestingly, the role(s) of Hippo signaling in NC development
are not well established, but the observations made here and by
others are consistent with a report showing the importance of
Hippo-YAP/TAZ in NC migration (Hindley et al., 2016).
The transcription factor PRRX1 was pinpointed as being
involved in MES/NCC-like identity by both recent landmark
studies on NB heterogeneity (Boeva et al., 2017; van Groningen
et al., 2017). Indeed, the first of these directly demonstrated
conversion of ADRN to MES lineages by PRRX1 induction in
SK-N-BE(2)-C cells. As we had reportedWnt3a/Rspo2 treatment
leading to EMT (Szemes et al., 2018), we investigated the
possible links between Wnt signaling and PRRX1. As shown
in Figure 4A, PRRX1 transcripts were significantly higher in
FIGURE 5 | The ADRN signature can be partitioned and the subgroups correlate with prognosis and neuroblastoma Wnt-regulated metagenes. (A) Heatmap
showing the expression of ADRN signature genes in risk groups of SEQC NB set (GSE62564) reveals two subgroups. (B) Kaplan-Meier analysis demonstrating that
the expression of the newly defined adrenergic low-risk (ADRN)-LR and adrenergic high-risk (HR) subgroups strongly and inversely correlate with prognosis.
(C) WMG-2 shows a strong positive correlation with ADRN-LR, and negatively correlates with ADRN-HR. ADRN-LR has a positive association with Hedgehog
signaling (Hallmark). ADRN-HR has a strong inverse correlation to WMG-1, and a positive correlation with WMG-3 and the expression of MYC targets-v1 (Hallmark).
(D) WMG-3 and 4 are highly expressed in ADRN cells relative to MES and NC cells, while the expression of WMG-2 is not significantly different among the cell types
(GSE14340 and GSE28019, van Groningen et al., 2017). Statistically significant difference between the groups was tested by using ANOVA (p values shown) and
Tukey HSD post hoc tests were applied to evaluate pairwise differences (∗∗∗p < 0.005, ∗p < 0.05). (E) Long-term (96 h) Wnt3a/Rspo-2 treatment of SK-N-BE(2)-C
cell can activate ADRN lineage transcription factors in NB cell lines.
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NB cluster 2 (intermediate risk, see Figure 2). Analyzing gene
expression changes accompanying PRRX1 induction in SK-N-
BE(2)-C cells, we found that WMG-1 genes, high expression of
which is characteristic of intermediate risk NB (Szemes et al.,
2018), showed increased expression following 144 h of PRRX1
induction, with the exceptions of MSX2 and BMP4, which were
increased at earlier timepoints (24–72 h). Expression of WMG-2
was also increased, although in a less uniform way, whereas
WMG-3 and WMG-4 genes appeared to be partitioned in their
response, with two subsets of genes regulated in an opposite
fashion (Figure 4B). In sum, we found a remarkable overlap
between our Wnt targets and the long-term transcriptional
effects of PRRX1 induction in SK-N-BE(2)-C. We conducted the
same analysis on Wnt pathway genes (KEGG and other known
members) and observed increased expression of Wnt pathway
receptor and transcriptional regulator genes accompanying
PRRX1 induction (Supplementary Figure S2).
Although the kinetics of WMG responses argues against
our Wnt genes being direct targets of PRRX1, this analysis
links PRRX1, Wnt signaling and MES identity. We note that
PRRX1 has been reported to be upstream of Wnt signaling
and regulating EMT in gastric cancer (Guo et al., 2015). We
also investigated whether Wnt signaling might form part of the
regulatory circuit involving PRRX1, and the Hippo regulator
TAZ (encoded by WWTR1), which were both implicated in
MES/NCC-like identity. As these were not identified in our
RNA sequencing timepoint (6 h), we assessed 96 h treatments
of SK-N-BE(2)-C and SH-SY5Y cell lines by qPCR. Both PRRX1
and WWTR1 were upregulated by greater than 2-fold in both
cell lines (Figure 4C), suggesting indirect regulation by Wnt
signaling. Finally, as we found strong interrelationships between
WMG-1 with Hippo-YAP/TAZ, and PRRX1, we tested the
possible link between PRRX1 and Hippo signaling. Evaluation
of the PRRX1 induction gene expression dataset revealed that
numerous genes encoding for members of the Hippo signaling
pathway were markedly upregulated, especially the Hippo
effectors YAP1, WWTR1, their interacting transcription factors,
SNAI2 and TEAD2, and the archetypal YAP/TAZ target gene
CTGF (Figure 4D). Taken together, this analysis supports Wnt
signaling as a major regulator of the MES/NCC-like identity
evident in NB.
Wnt signaling is known to crosstalk with Hippo-YAP/TAZ
signaling, and an alternativeWnt pathway has been characterized
showing that a non-canonical Wnt-YAP/TAZ signaling can
be initiated by Wnt3a or Wnt5a/b, which can then suppress
the canonical Wnt/β-catenin pathway (Park et al., 2015).
Although Wnt3a can activate both canonical and non-canonical
Wnt pathways (Samarzija et al., 2009), the majority of the
genes we identified in SK-N-BE(2)-C cells had been shown
to have β-catenin binding to their promoters (Szemes et al.,
2018). Furthermore, we did not see early effects on YAP and
TAZ proteins, or on CTGF expression (unpublished data)
of Wnt3a/Rspo2 treatment in NB cells. Whilst this supports
the early transcriptional response of SK-N-BE(2)-C cells to
Wnt3a/Rspo2 to be canonical Wnt/β-catenin signaling, we also
note that the non-canonical Wnt ligand genes, WNT5B and
WNT11, were amongst genes upregulated by our treatments
(Table 1). Thus, although it currently remains unclear what
the relative contributions of canonical and non-canonical Wnt
signaling are to NB cellular heterogeneity, it is evident that
canonicalWnt signaling is interacting with other trans regulators
to determine and maintain MES identity.
Our Wnt-driven NB phenotypes and transcriptome also
indicated neural differentiation in SK-N-BE(2)-C and SH-SY5Y
cell lines, including induction of NEFL and NEFM. In terms of
NB cellular identities, this suggests that Wnt may also influence
ADRN (or noradrenergic) cell fates. As a first step to analyzing
this possibility, we determined the expression pattern of the
ADRN signature genes in the four prognostic NB clusters
defined by the expression of our NB Wnt target genes (Szemes
et al., 2018; Supplementary Figure S3). ADRN genes had low
expression in NB cluster 2, dominated by the overexpression
of MES-related WMG-1. We also observed that the ADRN
genes clustered into two subsets according to expression in
the different prognostic Wnt groups. Therefore, we repeated
the clustering in the SEQC dataset according to clinical risk
categories and defined high-risk (ADRN-HR) and low-risk
ADRN (ADRN-LR) signatures, based on high expression of
the subsets in risk groups (Figure 5A). Contrasting expression
of these two ADRN subsets was particularly striking in MNA
tumors, which showed the highest expression of ADRN-HR
and the lowest of ADRN-LR genes. Kaplan-Meier survival
analyses showed that the ADRN-HR and ADRN-LR signatures
were, respectively, strong negative and positive prognostic
indicators (Figure 5B). We also found that ADRN-LR was
positively correlated with WMG-2, which in turn negatively
correlated with ADRN-HR. Evaluation of Hallmark genesets
highlighted a striking positive correlation of ADRN-LR with
TABLE 2 | Gene ontology analysis of adrenergic low-risk (ADRN-LR) and
adrenergic high-risk (HR) subgroups of genes.
GO ID Pathway description N FDR
ADRN-LR
GO.0007399 Nervous system development 52 6.16E-12
GO.0030182 Neuron differentiation 37 6.16E-12
GO.0048699 Generation of neurons 43 6.16E-12
GO.0022008 Neurogenesis 42 7.11E-11
GO.0048666 Neuron development 32 8.62E-11
GO.0031175 Neuron projection development 29 1.45E-10
GO.0048667 Cell morphogenesis involved in neuron
differentiation
24 1.30E-08
GO.0048731 System development 64 1.30E-08
GO.0048812 Neuron projection morphogenesis 24 1.69E-08




GO.0000278 Mitotic cell cycle 28 2.41E-06
GO.1903047 Mitotic cell cycle process 26 2.72E-06
GO.0022402 Cell cycle process 30 6.23E-06
GO.0007067 Mitotic nuclear division 17 1.77E-05
GO.0000280 Nuclear division 18 5.86E-05
GO.0007049 Cell cycle 32 5.86E-05
GO.0044772 Mitotic cell cycle phase transition 14 0.00085
GO.0006268 DNA unwinding involved in DNA
replication
4 0.00161
GO.0006271 DNA strand elongation involved in DNA
replication
5 0.0104
GO.0051301 Cell division 15 0.012
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Hedgehog signaling, as we had previously pointed out for
WMG-2 (Szemes et al., 2018; Figure 5C, top). The ADRN-HR
signature negatively correlated with WMG-1, but positively with
WMG-3, and accordingly, showed a very strong correlation
with an MYC signature (Figure 5C, bottom). Gene Ontology
analysis for ADRN-LR genes revealed enrichment for neuronal
development and differentiation pathways, and in contrast,
ADRN-HR genes were largely involved in cell-cycle processes,
proliferation (Table 2). In keeping with the strong association
between ADRN-HR and WMG-3 signatures, WMG-3 genes
were expressed at significantly higher levels in ADRN cells
compared to MES and NCC lines. WMG-4 displayed a similar
expression pattern, albeit with lower significance (Figure 5D).
WMG-2 was not significantly different between MES and ADRN
cell lines but was slightly lower in ADRN lines relative to
NCC lines.
Since we previously demonstrated that Wnt3a/Rspo2
treatment can prompt neural differentiation of NB cell lines,
we evaluated whether long-term (96 h) treatments with Wnt
ligands may influence transcription factors that contribute to the
establishment of the ADRN, or noradrenergic, cell lineage. As
shown in Figure 5E, PHOX2A/2B, TFAP2B and EYA1 were all
markedly upregulated in SK-N-BE(2)-C cells. In SH-SY5Y cells,
these factors were already generally higher, but again induction
of EYA1 was apparent following Wnt3a/Rspo2 treatment.
Taken together these analyses demonstrate that the ADRN
signature can be partitioned into two discrete subsets, which
we have termed ADRN-LR and ADRN-HR, with contrasting
expression in low-risk and high-risk NBs. The role of Wnt
in differentiation of sympathoadrenergic neurons is further
underlined by a report by Bodmer et al. (2009) that Wnt5a
promotes axonal growth and branching in response to
NGF:TrkA signaling. Our data also suggest co-operativity of
Wnt with Hedgehog signaling in establishing the ADRN-LR
signature. The role of Hedgehog signaling in NB remains
poorly understood and, as in the case of Wnt signaling,
there is conflicting evidence; two studies have suggested its
oncogenic potential (Mao et al., 2009; Xu et al., 2012), whereas
others have reported an influence on differentiation of NB
cells (Williams et al., 2000; Souzaki et al., 2010). A role for
Hedgehog signaling in cephalic and trunk NCC differentiation
has been reported (Calloni et al., 2007), and in Xenopus, the
Hedgehog transcription factor Gli2 was shown to be necessary
for NCC specification and migration (Cerrizuela et al., 2018).
In the context of NB, our previous studies suggested that
WMG-2 genes were correlated with Hedgehog signaling and
are suppressed by MYCN (Szemes et al., 2018). It, therefore,
follows that ADRN-LR genes, strongly associated with neural
development, may be Wnt/Hedgehog-regulated genes repressed
by MYCN. This informs and extends the suggestion that MYCN
represses signaling pathways driving differentiation during NB
tumorigenesis (Duffy et al., 2015).
SUMMARY AND PERSPECTIVES
The understanding of gene expression programmes, contingent
on transcription factor hierarchies and chromatin level plasticity,
in particular, epigenetic changes at super-enhancer elements,
continues to facilitate our understanding of cellular identity.
Notable advances have been made in ascertaining regulatory
circuits in NCCs as well as in neuroblastoma recently, yet
much remains to be determined about the contributions of
autocrine, paracrine and juxtacrine signaling pathways that,
together with transcription factors and epigenetic states, form a
regulatory triumvirate.
Our analysis of Wnt signaling strongly suggests that this
pathway is amajor determinant of transcription factor circuitries,
and thereby lineage identity, in neuroblastoma. This is further
supported by comparisons with NC GRNs, with Wnt signaling
regulating early NC specifiers such asMSX1 and DLX5/6, as well
as migratory factors such as SNAI2 and TWIST1/2. Further, we
highlight the possible interplay between canonical Wnt signaling
with Hippo-YAP/TAZ andHedgehog signaling, emphasizing the
need for integrative analysis of signaling inputs for both NC and
NB biology. Our transcriptomic signatures facilitate this, but also
underline the need for parallel studies using diverse cell types and
signaling effectors.
With regard to NB, our study begins to reconcile some
of the apparent contradictions about the influence of Wnt
signaling. The determination of MES/NCC-like identity by
Wnt is consistent with reports that resistance to chemotherapy
and stemness may be linked to Wnt (Flahaut et al., 2009;
Cantilena et al., 2011; Vangipuram et al., 2012). However,
as we have shown, there are also Wnt-driven gene modules
linked to neuronal differentiation. We propose that establishing
a ‘‘Signaling Regulatory Network’’ will aid the formulation of
a novel and efficacious treatment combinations for resistant
neuroblastoma and differentiation therapies.
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